Ascendis Pharma A/S Net Foreign Exchange Loss
Ascendis Pharma A/S (ASND) reported Net Foreign Exchange Loss of EUR 0 for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:NetForeignExchangeLoss · last filed 2026-02-11
| Period end | Net Foreign Exchange Loss 12 month |
|---|---|
| 2025-12-31 | 0.00 EUR 20-F · filed 2026-02-11 |
| 2024-12-31 | 27.15M EUR 20-F · filed 2026-02-11 |
| 2023-12-31 | 0.00 EUR 20-F · filed 2026-02-11 |
| 2022-12-31 | 4.32M EUR 20-F · filed 2025-02-12 |
| 2020-12-31 | 78.92M EUR 20-F · filed 2023-02-16 |
| 2017-12-31 | 13.66M EUR 20-F · filed 2020-04-03 |
| 2016-12-31 | 3.11M EUR 20-F · filed 2019-04-03 |
| 2015-12-31 | 2.79M EUR 20-F · filed 2018-03-28 |